Literature DB >> 29673441

YWHAZ Binds to TRIM21 but Is Not Involved in TRIM21-stimulated Osteosarcoma Cell Proliferation.

Qing Zhong Zeng1, Wan Ting Liu1, Jun Lei Lu1, Xiao Hui Liu1, Yun Fang Zhang2, Lang Xia Liu1, Xue Juan Gao1.   

Abstract

OBJECTIVE: Osteosarcoma is the most common type of malignant bone tumor in children and adolescents. The role of E3 ligases in tumorigenesis is currently a focus in tumor research. In the present study, we investigated the role of the E3 ligase tripartite motif 21 (TRIM21) in osteosarcoma cell proliferation.
METHODS: 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assays were used to assess osteosarcoma cell viability. U2-OS cells stably carrying a recombinant lentivirus expressing tetracycline-regulated TRIM21 were screened. Co-immunoprecipitation was coupled with LCMS/MS analysis to identify novel interacting partners of TRIM21. Co-immunoprecipitation and bimolecular fluorescence complementation (BIFC) were performed to validate the interactions between TRIM21 and its novel partner YWHAZ. A TRIM21-ΔRING construct was generated to test the effects of TRIM21 ligase activity on YWHAZ.
RESULTS: TRIM21 positively regulated osteosarcoma cell proliferation. Overexpression of TRIM21 enhanced osteosarcoma cell tolerance toward various stresses. YWHAZ protein was identified as a novel interacting partner of TRIM21 and its expression levels were negatively regulated by TRIM21. The RING domain of TRIM21 was required for TRIM21 negative regulation of YWHAZ expression. However, overexpression of YWHAZ did not affect positive regulation of osteosarcoma cell proliferation by TRIM21.
CONCLUSION: Our results further clarify the molecular mechanisms underlying the pathogenesis of osteosarcoma.
Copyright © 2018 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Osteosarcoma; Proliferation; TRIM21; YWHAZ

Mesh:

Substances:

Year:  2018        PMID: 29673441     DOI: 10.3967/bes2018.024

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  7 in total

1.  Cytoplasmic PCNA is located in the actin belt and involved in osteoclast differentiation.

Authors:  Donge Tang; Xiaohui Liu; Kezhi Chen; Zhipeng Li; Yong Dai; Jiake Xu; Huan-Tian Zhang; Xuejuan Gao; Langxia Liu
Journal:  Aging (Albany NY)       Date:  2020-06-27       Impact factor: 5.682

2.  PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP/p21 axis.

Authors:  Yu-Hang Li; Kui-Leung Tong; Jun-Lei Lu; Jie-Bin Lin; Zhen-Yan Li; Yuan Sang; Abdelmoumin Ghodbane; Xue-Juan Gao; Man-Seng Tam; Chang-Deng Hu; Huan-Tian Zhang; Zhen-Gang Zha
Journal:  Aging (Albany NY)       Date:  2020-02-05       Impact factor: 5.682

3.  TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy.

Authors:  Huan-Tian Zhang; Qingzhong Zeng; Baomeng Wu; Junlei Lu; Kui-Leung Tong; Jiebin Lin; Qiu-Yu Liu; Lipei Xu; Jie Yang; Xiaohui Liu; Wanting Liu; Yun-Fang Zhang; Qionghua Lian; Langxia Liu; Xuejuan Gao
Journal:  Cell Death Dis       Date:  2021-01-06       Impact factor: 8.469

4.  A novel immune-related gene signature predicting survival in sarcoma patients.

Authors:  Haoyu Ren; Alexandr V Bazhin; Elise Pretzsch; Sven Jacob; Haochen Yu; Jiang Zhu; Markus Albertsmeier; Lars H Lindner; Thomas Knösel; Jens Werner; Martin K Angele; Florian Bösch
Journal:  Mol Ther Oncolytics       Date:  2021-12-09       Impact factor: 7.200

5.  Negative feedback regulation by HuR controls TRIM21 expression and function in response to UV radiation.

Authors:  Abhishek Guha; Sharanya Nag; Partho Sarothi Ray
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

6.  Experimental Study of Somatic Variants of Osteosarcoma by Whole-Exome Sequencing.

Authors:  Jingyu Hou; Guoqing Liu; Peng Zhang; Bangmin Wang; Qiang Yan; Pin Wu; Chuchu Wang; Weitao Yao
Journal:  Med Sci Monit       Date:  2020-03-20

7.  Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR.

Authors:  Wenwei Jiang; Xinyu Cai; Tianyang Xu; Kaiyuan Liu; Dong Yang; Lin Fan; Guodong Li; Xiao Yu
Journal:  Oncol Res       Date:  2020-04-15       Impact factor: 5.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.